X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16) 16
oncology (16) 16
humans (14) 14
obstetrics & gynecology (12) 12
breast cancer (10) 10
female (9) 9
middle aged (9) 9
adult (7) 7
medizin (7) 7
research (7) 7
breast neoplasms - drug therapy (6) 6
animals (5) 5
chemotherapy (5) 5
expression (5) 5
germany (5) 5
history (5) 5
male (5) 5
therapy (5) 5
trastuzumab (5) 5
bibliography (4) 4
biography (4) 4
breast neoplasms - pathology (4) 4
cancer (4) 4
cell biology (4) 4
disease-free survival (4) 4
further section · weitere sektionen (4) 4
orthopedics (4) 4
rats (4) 4
surgery (4) 4
tissue engineering (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
autism (3) 3
care and treatment (3) 3
cartilage (3) 3
case-control studies (3) 3
criticism and interpretation (3) 3
diagnosis (3) 3
expert discussion · expertenplenum (3) 3
follow-up (3) 3
further section (3) 3
german (3) 3
hematology, oncology and palliative medicine (3) 3
identification (3) 3
medicine & public health (3) 3
oncology, experimental (3) 3
patients (3) 3
prognosis (3) 3
receptor, erbb-2 - genetics (3) 3
recurrence (3) 3
adolescent (2) 2
advanced breast cancer (2) 2
aged (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
apoptosis (2) 2
articular-cartilage (2) 2
biotechnology & applied microbiology (2) 2
brain metastases (2) 2
breast neoplasms - genetics (2) 2
breast neoplasms - mortality (2) 2
breast neoplasms - psychology (2) 2
cancer therapies (2) 2
cell & tissue engineering (2) 2
cells (2) 2
children (2) 2
chondrocytes (2) 2
christianity (2) 2
church history (2) 2
clinical information · klinische information (2) 2
cohort studies (2) 2
congresses (2) 2
degeneration (2) 2
deutschland (2) 2
dictionaries (2) 2
early printed books (2) 2
endocrine therapy (2) 2
enzyme-linked immunosorbent assay (2) 2
expert discussion (2) 2
expertenplenum · expert discussion (2) 2
genetic aspects (2) 2
geschichte (2) 2
growth (2) 2
growth factors (2) 2
guidelines (2) 2
her2-positive (2) 2
history and criticism (2) 2
immunohistochemistry (2) 2
in vivo (2) 2
ligands (2) 2
medical prognosis (2) 2
medizinische fakultät (2) 2
metastasis (2) 2
metastatic breast cancer (2) 2
methods (2) 2
monoclonal-antibody (2) 2
motion pictures (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (15) 15
UTL at Downsview - May be requested (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Knox College (Caven) - Reference (1) 1
Music - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Reference (1) 1
Regis College - Reference (1) 1
Robarts - Moving to offsite: no requests (1) 1
Robarts - Storage (1) 1
Victoria University CRRS - May be requested (1) 1
Victoria University Emmanuel College - Birge Storage (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 887 - 896
Summary Background Little is known about the treatment of breast cancer during pregnancy. We aimed to determine whether treatment for breast cancer during... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | PROGNOSIS | PRETERM BIRTH | OUTCOMES | TAXANES | MODEL | ANTHRACYCLINES | CHEMOTHERAPY | CHILDREN | FEATURES | AGE | Breast Neoplasms - surgery | Multivariate Analysis | Carcinoma, Lobular - pathology | Infant, Newborn, Diseases - epidemiology | Birth Weight - drug effects | Carcinoma, Ductal - pathology | Humans | Middle Aged | Organ Preservation | Male | Infant, Newborn, Diseases - chemically induced | Carcinoma, Ductal - drug therapy | Pregnancy Outcome - epidemiology | Incidence | Young Adult | Apgar Score | Pregnancy Complications, Neoplastic - drug therapy | Adult | Female | Registries | Retrospective Studies | Infant, Newborn | Carcinoma, Lobular - secondary | Carcinoma, Lobular - surgery | Abnormalities, Drug-Induced - epidemiology | Europe | Lymphatic Metastasis | Carcinoma, Lobular - diagnosis | Breast Neoplasms - drug therapy | Pregnancy | Disease-Free Survival | Carcinoma, Ductal - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Carcinoma, Ductal - diagnosis | Breast Neoplasms - diagnosis | Carcinoma, Lobular - drug therapy | Delivery, Obstetric - statistics & numerical data | Neoplasm Staging | Cohort Studies | Care and treatment | Surgery, Plastic | Surgical clinics | Pregnant women | Oncology, Experimental | Breast cancer | Research | Drug therapy | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 3, pp. 244 - 248
Journal Article
BMC Medicine, ISSN 1741-7015, 10/2018, Volume 16, Issue 1, pp. 179 - 16
Journal Article
Archives of Gynecology and Obstetrics, ISSN 0932-0067, 2/2016, Volume 293, Issue 2, pp. 271 - 281
The aim of the ongoing DETECT study program is to evaluate therapeutic intervention based on phenotypes of circulating tumor cells (CTC) in patients with... 
Human Genetics | Circulating tumor cells (CTC) | DETECT study program | Medicine & Public Health | Advanced breast cancer | Endocrine responsiveness score | Targeted therapy | Gynecology | Obstetrics/Perinatology | HER2-phenotype of CTC | Endocrinology | Q-TWIST | ADJUSTED SURVIVAL ANALYSIS | CHEMOTHERAPY | OBSTETRICS & GYNECOLOGY | MESENCHYMAL TRANSITION MARKERS | ANDROGEN RECEPTOR EXPRESSION | RESISTANCE | STEM-CELL | QUALITY-OF-LIFE | DISTANT METASTASES | ASSOCIATION | Neoplastic Cells, Circulating - pathology | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Neoplastic Cells, Circulating - metabolism | Neoplasm Metastasis | Biomarkers, Tumor - metabolism | Adult | Female | Molecular Targeted Therapy - methods | Neoplastic Cells, Circulating - drug effects | Antibodies, Monoclonal, Humanized - therapeutic use | Trastuzumab - therapeutic use | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Phenotype | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Breast Neoplasms - psychology | Quinazolines - therapeutic use | Quality of Life | Breast Neoplasms - mortality | Biomarkers, Tumor - genetics | Chemotherapy | Oncology, Experimental | Breast cancer | Genetic aspects | Postmenopausal women | Metastasis | Research | Health aspects | Cancer | Endocrine therapy | Cancer therapies
Journal Article
Breast Care, ISSN 1661-3791, 07/2015, Volume 10, Issue 3, pp. 157 - 158
Journal Article
Stem Cell Reviews and Reports, ISSN 1550-8943, 12/2018, Volume 14, Issue 6, pp. 847 - 859
Journal Article
Journal Article
Breast Care, ISSN 1661-3791, 03/2013, Volume 8, Issue 1, pp. 49 - 55
The humanized monoclonal antibody pertuzumab prevents the dimerization of HER2 with other HER receptors, in particular the pairing of the most potent signaling... 
Review Article · Übersichtsarbeit | Breast cancer, metastatic | Pertuzumab | Dual inhibition | Trastuzumab | HER2-positive | ADJUVANT CHEMOTHERAPY | metastatic | SAFETY | RECEPTOR | Breast cancer | MONOCLONAL-ANTIBODY | OPEN-LABEL | OBSTETRICS & GYNECOLOGY | SINGLE-AGENT PERTUZUMAB | ONCOLOGY | RANDOMIZED PHASE-II | RHUMAB 2C4 | NEOADJUVANT PERTUZUMAB | Review · Übersichtsarbeit
Journal Article
Breast Care, ISSN 1661-3791, 03/2018, Volume 13, Issue 1, pp. 48 - 58
The Advanced Breast Cancer Fourth Consensus (ABC4) on diagnosis and treatment of advanced breast cancer (ABC) again took place in Lisbon, on November 2-4,... 
Consensus | Brain metastases | Advanced breast cancer | ABC4 | Personalized medicine | BRCA-Associated | HR-positive/HER2-positive | BRCA-associated | ADVANCED BREAST-CANCER | GUIDELINES | AGO RECOMMENDATIONS | OBSTETRICS & GYNECOLOGY | PALBOCICLIB | ONCOLOGY | FULVESTRANT | DOUBLE-BLIND | PHASE-3 TRIAL | UPDATE 2017 | 1ST-LINE THERAPY
Journal Article